At just five years old, Charlotte Figi changed the world's view of CBD. Her battle against a rare disease paved the way for scientific research, changes in the law, and medical acceptance of medical cannabis.
Key Takeaways
- Charlotte Figi suffered from a severe form of epilepsy that was resistant to all known treatments.
- The use of CBD has drastically reduced his seizures, sparking global interest in this compound.
- His story has accelerated research, influenced legislation, and changed the public perception of medical cannabis.
Table of Contents
A Child at the Center of a Medical Battle
Charlotte Figi was born in 2006 in Colorado, in the United States. She began having her first epileptic seizures at the age of two. Doctors diagnosed her with Dravet syndrome, a rare and severe form of childhood epilepsy that is often resistant to all forms of drug treatment.
Despite constant care and more than a dozen treatments, nothing is helping. Theseizures are getting worse; some of them cause her to stop breathing and pose a direct threat to her life.
Her parents, Paige and Matt Figi, tried every medical option available, from acupuncture to special diets to experimental medications. Nothing helped stabilize their daughter. In 2011, Charlotte was having as many as 300 seizures a week. The family was on the verge of despair.
That’s when Matt came across online accounts of children with epilepsy who had been successfully treated with cannabis that was high in CBD and low in THC. Although they had no experience in this area, the Figi family decided to give it a try.
Under medical supervision, Charlotte is given CBD oil specially formulated to minimize psychotropic effects. Within a few days, the results are remarkable, and theseizures decrease drastically—from hundreds per week to just one every few days.
For the first time in years, Charlotte can talk, eat on her own, play, and live a normal life. This change has taken her family and friends—as well as the medical community—by surprise.
A Turning Point for CBD Research and Legislation
Charlotte's dramatic improvement quickly caught the attention of the American media. Networks like CNN broadcast her story around the world, sparking an unprecedented wave of interest in CBD for therapeutic purposes.
Testimonials from his family and doctors have brought about a real shift in attitudes: cannabis is no longer associated solely with recreational use; it has become a legitimate subject of scientific and medical study.
Under pressure from public opinion and patient advocacy groups, several U.S. states, including Colorado, began relaxing their medical cannabis laws as early as 2014.
Researchers then began to seriously study the anticonvulsant properties of cannabidiol.
A global movement is taking shape
Clinics and laboratories are gearing up to conduct clinical trials on CBD. Governments are reevaluating the classifications of cannabis and its derivatives. Families facing similar medical conditions are calling for regulated access to these treatments.
Scientific findings are beginning to confirm what Charlotte’s experience had led us to hope: CBD acts on the endocannabinoid system by modulating the brain’s electrical activity, thereby reducing the neural discharges responsible for seizures.
In 2018, the FDA approved the drug Epidiolex, which is made from purified CBD for epilepsy, marked a historic milestone. It is the first cannabis-derived drug to be approved on a large scale, particularly for Dravet syndrome.
Charlotte thus becomes, despite herself, the face of a major medical and political turning point.
Global Inspiration and a Lasting Legacy
Charlotte Figi’s story goes beyond the medical realm. It symbolizes the recognition of CBD’s therapeutic value and the humanization of a debate that has long been stifled by fear and stigma.
Her experience has inspired many researchers, doctors, and activists. It has also prompted manufacturers to develop CBD products that are safer, more accurately dosed, and better regulated.
Healthcare institutions, for their part, have begun to publish guidelines to regulate the medical use of cannabidiol, particularly in the treatment of treatment-resistant epilepsy.
Beyond science, Charlotte changed people's mindsets. Thanks to her, society came to understand that it was possible to talk about cannabis openly, study it seriously, and use it for therapeutic purposes.
Even today, thousands of families around the world benefit from CBD-based treatments. Their very existence, their quality of life, and their medical recognition all stem from the courage of a little girl and her parents.
Charlotte Figi passed away in 2020 at the age of 13, but her legacy lives on. She made CBD a part of history—not just as a molecule, but as a source of hope, science, and humanity.
Benjamin Poirel-Nadal
Fascinated by natural wellness and plants with soothing properties, I have been exploring the various forms and uses of CBD for several years.
My goal: to share reliable information, honest opinions, and practical advice to help you fully enjoy the benefits of hemp with confidence and peace of mind.
